JESSICA NAUNAS: Open Payments
NPI 1699980508 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 16 payments from 11 companies in 2025. Trend: 2023 $290 · 2024 $70 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $48 |
| PFIZER INC. | 2 | $42 |
| GENZYME CORPORATION | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Genentech USA, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $15 |
Products named: ERLEADA, DATROWAY, ENHERTU, AYVAKIT, IBRANCE, OPDUALAG, TALVEY, Polivy.
Industry payments across GA — which companies pay providers there.
